Proto Labs Reports Record Revenue and Net Income for the Fourth Quarter 2013
Quarterly Revenue Increases 31% Year over Year to
Quarterly
Net Income Increases 29% Year over Year to
Highlights include:
-
Revenue for the fourth quarter of 2013 increased to a record
$44.0 million , 31 percent above revenue of$33.6 million in the fourth quarter of 2012. - The record quarterly revenue was achieved through a 21 percent increase in the number of product developers served combined with an increase of 9 percent in spending per product developer.
-
Net income for the fourth quarter of 2013 increased to a record
$9.5 million , or$0.36 per diluted share. Non-GAAP net income, excluding the after tax expense of stock compensation, was$10.2 million , or$0.39 per diluted share. See “Non-GAAP Financial Measure” below.
“I am very proud of our many accomplishments in the fourth quarter of
2013, my last as CEO,” said
Additional highlights include:
- Gross margin was 62.7 percent of revenue in the fourth quarter of 2013 compared with 62.5 percent during the same quarter in 2012.
-
During the fourth quarter of 2013, spending on research and
development, including the Protoworks initiatives, totaled
$3.5 million , or 7.9 percent of revenue. This compares to$2.5 million , or 7.5 percent of revenue during the fourth quarter of 2012. - Operating margin was 31.5 percent of revenue during the fourth quarter of 2013 compared to 30.5 percent in the fourth quarter of 2012.
-
As measured on a year to date basis, cash generated from operations
totaled
$48.4 million and expenditures on capital equipment were$18.8 million . Cash and cash equivalents and investments totaled$143.4 million as ofDecember 31, 2013 .
“As part of the
Non-GAAP Financial Measure
The company has included non-GAAP net income, adjusted for stock-based compensation expense in this press release to provide investors with additional information regarding the company’s financial results. The company has provided below a reconciliation of non-GAAP net income, adjusted for stock-based compensation expense, to net income, the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP net income, adjusted for stock-based compensation expense, is used by the company’s management and board of directors to understand and evaluate operating performance and trends and provides a useful measure for period-to-period comparisons of the company’s business. Accordingly, the company believes that non-GAAP net income, adjusted for stock-based compensation expense, provides useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.
Conference Call
The company has scheduled a conference call to discuss its fourth
quarter financial results today,
About
Forward-Looking Statements
Statements contained in this
press release regarding matters that are not historical or current facts
are “forward-looking statements” within the meaning of The Private
Securities Litigation Reform Act of 1995. These statements involve known
and unknown risks, uncertainties and other factors which may cause the
results of
Proto Labs, Inc. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(In thousands) | ||||||||
December 31, | December 31, | |||||||
2013 | 2012 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 43,039 | $ | 36,759 | ||||
Short-term marketable securities | 36,339 | 25,137 | ||||||
Accounts receivable, net | 18,320 | 15,791 | ||||||
Inventory | 5,166 | 4,619 | ||||||
Other current assets | 6,931 | 7,850 | ||||||
Total current assets | 109,795 | 90,156 | ||||||
Property and equipment, net | 56,101 | 45,316 | ||||||
Long-term marketable securities | 64,023 | 36,965 | ||||||
Other long-term assets | 256 | 285 | ||||||
Total assets | $ | 230,175 | $ | 172,722 | ||||
Liabilities and shareholders' equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 6,455 | $ | 4,758 | ||||
Accrued compensation | 6,196 | 5,995 | ||||||
Accrued liabilities and other | 808 | 513 | ||||||
Current portion of long-term debt obligations | 204 | 273 | ||||||
Total current liabilities |
13,663 | 11,539 | ||||||
Long-term deferred tax liabilities | 3,682 | 3,346 | ||||||
Long-term debt obligations | 159 | 356 | ||||||
Other long-term liabilities | 1,028 | 782 | ||||||
Shareholders' equity | 211,643 | 156,699 | ||||||
Total liabilities and shareholders' equity | $ | 230,175 | $ | 172,722 | ||||
Proto Labs, Inc. | ||||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||||
(In thousands, except share and per share amounts) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2013 |
2012 |
2013 |
2012 |
|||||||||||||
Revenues | ||||||||||||||||
Protomold | $ | 30,731 | $ | 23,674 | $ | 115,069 | $ | 90,371 | ||||||||
Firstcut | 13,311 | 9,942 | 48,043 | 35,620 | ||||||||||||
Total revenues |
44,042 | 33,616 | 163,112 | 125,991 | ||||||||||||
Cost of revenues | 16,427 | 12,611 | 61,410 | 49,853 | ||||||||||||
Gross profit | 27,615 | 21,005 | 101,702 | 76,138 | ||||||||||||
Operating expenses | ||||||||||||||||
Marketing and sales | 6,164 | 4,658 | 22,386 | 18,098 | ||||||||||||
Research and development | 3,458 | 2,515 | 11,863 | 9,137 | ||||||||||||
General and administrative | 4,119 | 3,564 | 16,154 | 13,957 | ||||||||||||
Total operating expenses | 13,741 | 10,737 | 50,403 | 41,192 | ||||||||||||
Income from operations | 13,874 | 10,268 | 51,299 | 34,946 | ||||||||||||
Other income, net | 129 | 114 | 279 | 23 | ||||||||||||
Income before income taxes | 14,003 | 10,382 | 51,578 | 34,969 | ||||||||||||
Provision for income taxes | 4,496 | 2,987 | 16,301 | 10,944 | ||||||||||||
Net income | $ | 9,507 | $ | 7,395 | $ | 35,277 | $ | 24,025 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 0.37 | $ | 0.30 | $ | 1.40 | $ | 1.03 | ||||||||
Diluted | $ | 0.36 | $ | 0.29 | $ | 1.36 | $ | 0.98 | ||||||||
Shares used to compute net income per share: | ||||||||||||||||
Basic | 25,506,107 | 24,557,878 | 25,198,556 | 23,373,593 | ||||||||||||
Diluted | 26,115,866 | 25,359,071 | 25,859,741 | 24,443,665 | ||||||||||||
Proto Labs, Inc. | ||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||
(In thousands) | ||||||||||
(Unaudited) | ||||||||||
Year Ended | ||||||||||
December 31, | ||||||||||
2013 | 2012 | |||||||||
Operating activities | ||||||||||
Net income | $ | 35,277 | $ | 24,025 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | 7,569 | 6,080 | ||||||||
Stock-based compensation expense | 3,461 | 3,039 | ||||||||
Deferred taxes | 467 | (583 | ) | |||||||
Excess tax benefit from stock-based compensation | (9,873 | ) | (6,218 | ) | ||||||
Amortization of held-to-maturity securities | 1,468 | 369 | ||||||||
Loss on disposal of property and equipment | 110 | 154 | ||||||||
Changes in operating assets and liabilities | 9,962 | (1,191 | ) | |||||||
Net cash provided by operating activities | 48,441 | 25,675 | ||||||||
Investing activities | ||||||||||
Purchases of property and equipment | (18,753 | ) | (17,397 | ) | ||||||
Purchases of marketable securities | (106,298 | ) | (84,588 | ) | ||||||
Proceeds from maturities of marketable securities | 66,570 | 22,368 | ||||||||
Net cash used in investing activities | (58,481 | ) | (79,617 | ) | ||||||
Financing activities | ||||||||||
Proceeds from initial public offering, net of offering costs | - | 71,530 | ||||||||
Proceeds from follow-on offering, net of offering costs | - | 2,451 | ||||||||
Payments on debt | (258 | ) | (388 | ) | ||||||
Proceeds from exercises of stock options and other | 6,496 | 2,975 | ||||||||
Excess tax benefit from stock-based compensation | 9,873 | 6,218 | ||||||||
Net cash provided by financing activities | 16,111 | 82,786 | ||||||||
Effect of exchange rate changes on cash and cash equivalents | 209 | (220 | ) | |||||||
Net increase in cash and cash equivalents | 6,280 | 28,624 | ||||||||
Cash and cash equivalents, beginning of period | 36,759 | 8,135 | ||||||||
Cash and cash equivalents, end of period | $ | 43,039 | $ | 36,759 | ||||||
Proto Labs, Inc. | ||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measure | ||||||||||
(In thousands, except share and per share amounts) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | Year Ended | |||||||||
December 31, 2013 | December 31, 2013 | |||||||||
Non-GAAP net income, adjusted for stock-based compensation expense: | ||||||||||
GAAP net income | $ | 9,507 | $ | 35,277 | ||||||
Add back: Stock-based compensation expense | ||||||||||
Cost of revenue | 83 | 316 | ||||||||
Marketing and sales | 155 | 610 | ||||||||
Research and development | 199 | 754 | ||||||||
General and administrative | 429 | 1,781 | ||||||||
Total stock-based compensation expense | 866 | 3,461 | ||||||||
Less: Tax benefit on stock-based compensation | (223 | ) | (847 | ) | ||||||
Non-GAAP net income | $ | 10,150 | $ | 37,891 | ||||||
Non-GAAP net income per share: | ||||||||||
Basic | $ | 0.40 | $ | 1.50 | ||||||
Diluted | $ | 0.39 | $ | 1.47 | ||||||
Shares used to compute non-GAAP net income per share: | ||||||||||
Basic | 25,506,107 | 25,198,556 | ||||||||
Diluted | 26,115,866 | 25,859,741 | ||||||||
Proto Labs, Inc. | ||||||||||||||||
Revenue by Geography - Based on Shipping Location | ||||||||||||||||
(In thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2013 |
2012 |
2013 |
2012 |
|||||||||||||
Revenues | ||||||||||||||||
Domestic | ||||||||||||||||
United States | $ | 31,054 | $ | 24,979 | $ | 119,870 | $ | 94,866 | ||||||||
International | ||||||||||||||||
Europe | 9,653 | 6,212 | 31,513 | 22,517 | ||||||||||||
Japan | 1,604 | 1,396 | 5,857 | 4,814 | ||||||||||||
United States | 1,731 | 1,029 | 5,872 | 3,794 | ||||||||||||
Total international | 12,988 | 8,637 | 43,242 | 31,125 | ||||||||||||
Total revenue | $ | 44,042 | $ | 33,616 | $ | 163,112 | $ | 125,991 | ||||||||
Proto Labs, Inc. | ||||||||||||||
Customer Information | ||||||||||||||
(In thousands, except customer amounts) | ||||||||||||||
(Unaudited) | ||||||||||||||
Year Ended December 31, | ||||||||||||||
2013 | 2012 | |||||||||||||
Number of | Number of | |||||||||||||
Customers | Revenue ($) | Customers | Revenue ($) | |||||||||||
New customers | 3,027 | $ | 22,532 | 2,991 | $ | 20,766 | ||||||||
Existing customers | 5,734 | 140,580 | 4,763 | 105,225 | ||||||||||
Total | 8,761 | $ | 163,112 | 7,754 | $ | 125,991 | ||||||||
Proto Labs, Inc. | ||||||||||||
Product Developer Information | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended |
Year Ended | |||||||||||
December 31, | December 31, | |||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||
Unique product developers served | 7,290 | 6,042 | 16,128 | 13,454 | ||||||||
Source:
Proto Labs, Inc.
Investor Relations:
Jack Judd,
763-479-7408
jack.judd@protolabs.com
or
Media
Relations:
Bill Dietrick, 763-479-7664
bill.dietrick@protolabs.com